×
About 6,604 results

ALLMedicine™ HDL Cholesterol Center

Research & Reviews  2,935 results

Mutual effect modification between adiponectin and HDL as risk factors of cardiovascula...
https://doi.org/10.1007/s11255-021-02828-4 10.1177/2047487319878371 10.1172/JCI29126 10.1161/CIRCULATIONAHA.106.618918 10.2174/092986712803833164 10.1161/01.ATV.20.6.1595 10.1016/j.beem.2013.08.006 10.1161/01.CIR.103.8.1057 10.1016/j.cccn.2004.02.020 10.1016/S0021-9150(01)00651-7 10.7326/0003-4819-150-9-200905050-00006 10.1016/j.jdiacomp.2017.06.012 10.1155/2015/507265 10.1038/ki.2008.645 10.1080/01621459.1999.10474144 10.1002/sim.4780030207 10.1038/ki.2008.416 10.1177/2047487313514894 10.1016/j.atherosclerosis.2006.11.017 10.1159/000334649 10.1111/1744-9987.12065 10.1016/j.clinbiochem.2015.05.013 10.1038/ki.2008.201 10.2169/internalmedicine.47.0614 10.1097/00004872-200018090-00006 10.14310/horm.2002.1698 10.1016/j.metabol.2016.03.008 10.1159/000330178 10.1016/j.atherosclerosis.2010.01.001 10.2337/diacare.27.7.1680 10.1681/ASN.2006040331 10.1155/2019/3021785 10.1016/j.atherosclerosis.2013.01.017 10.1016/s0014-5793(03)00568-4 10.1155/2017/3081856 10.1016/j.metabol.2015.11.011 10.1194/jlr.M030213 10.1210/jc.2008-1457 10.1016/j.bbrc.2007.05.040 10.1016/j.atherosclerosis.2010.01.001 10.1016/j.metabol.2017.01.002 10.1016/j.atherosclerosis.2016.07.897 10.1194/jlr.P002816
International Urology and Nephrology; Roumeliotis S, Liakopoulos V et. al.

Mar 6th, 2021 - We aimed to assess whether high-density lipoprotein (HDL) cholesterol modifies the association between adiponectin and incident cardiovascular (CV) morbidity and mortality in Type 2 Diabetes Mellitus (T2DM) and vice versa. At baseline, 106 T2DM pa...

Association of serum HDL cholesterol and apolipoprotein A1 levels with risk of severe S...
https://doi.org/10.1016/j.jlr.2021.100061
Journal of Lipid Research; Hilser JR, Han Y et. al.

Mar 5th, 2021 - Individuals with features of metabolic syndrome are particularly susceptible to SARS-CoV-2, a novel coronavirus associated with the severe respiratory disease COVID-19. Despite considerable attention dedicated to COVID-19, the link between metabol...

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901093
Arthritis Research & Therapy; Ferraz-Amaro I, Delgado-Frías E et. al.

Feb 24th, 2021 - It is well established that patients with systemic sclerosis (SSc) have a disrupted lipid profile and an increased cardiovascular risk. Cholesterol efflux capacity (CEC), the ability of high-density lipoprotein (HDL)-cholesterol to accept choleste...

Impact of high visceral adiposity index associated with metabolic syndrome on erectile ...
https://doi.org/10.1111/ijcp.14111
International Journal of Clinical Practice; Bolat MS, Ozbek ML et. al.

Feb 23rd, 2021 - Erectile dysfunction (ED) is a common condition affected by many factors. We aimed to show the impact of the metabolic syndrome (MeTS) on male sexual function based on visceral adiposity index (VAI). Participants who met MeTS criteria (Group 1, n ...

A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897392
Lipids in Health and Disease; Xie B, He J et. al.

Feb 22nd, 2021 - Poor cholesterol efflux capacity (CEC) has been proposed to be an independent risk factor for cardiovascular diseases. However, current evidence is inconsistent, especially in rheumatoid arthritis (RA) patients. This meta-analysis aims to identify...

see more →

Clinicaltrials.gov  3,229 results

Mutual effect modification between adiponectin and HDL as risk factors of cardiovascula...
https://doi.org/10.1007/s11255-021-02828-4 10.1177/2047487319878371 10.1172/JCI29126 10.1161/CIRCULATIONAHA.106.618918 10.2174/092986712803833164 10.1161/01.ATV.20.6.1595 10.1016/j.beem.2013.08.006 10.1161/01.CIR.103.8.1057 10.1016/j.cccn.2004.02.020 10.1016/S0021-9150(01)00651-7 10.7326/0003-4819-150-9-200905050-00006 10.1016/j.jdiacomp.2017.06.012 10.1155/2015/507265 10.1038/ki.2008.645 10.1080/01621459.1999.10474144 10.1002/sim.4780030207 10.1038/ki.2008.416 10.1177/2047487313514894 10.1016/j.atherosclerosis.2006.11.017 10.1159/000334649 10.1111/1744-9987.12065 10.1016/j.clinbiochem.2015.05.013 10.1038/ki.2008.201 10.2169/internalmedicine.47.0614 10.1097/00004872-200018090-00006 10.14310/horm.2002.1698 10.1016/j.metabol.2016.03.008 10.1159/000330178 10.1016/j.atherosclerosis.2010.01.001 10.2337/diacare.27.7.1680 10.1681/ASN.2006040331 10.1155/2019/3021785 10.1016/j.atherosclerosis.2013.01.017 10.1016/s0014-5793(03)00568-4 10.1155/2017/3081856 10.1016/j.metabol.2015.11.011 10.1194/jlr.M030213 10.1210/jc.2008-1457 10.1016/j.bbrc.2007.05.040 10.1016/j.atherosclerosis.2010.01.001 10.1016/j.metabol.2017.01.002 10.1016/j.atherosclerosis.2016.07.897 10.1194/jlr.P002816
International Urology and Nephrology; Roumeliotis S, Liakopoulos V et. al.

Mar 6th, 2021 - We aimed to assess whether high-density lipoprotein (HDL) cholesterol modifies the association between adiponectin and incident cardiovascular (CV) morbidity and mortality in Type 2 Diabetes Mellitus (T2DM) and vice versa. At baseline, 106 T2DM pa...

Association of serum HDL cholesterol and apolipoprotein A1 levels with risk of severe S...
https://doi.org/10.1016/j.jlr.2021.100061
Journal of Lipid Research; Hilser JR, Han Y et. al.

Mar 5th, 2021 - Individuals with features of metabolic syndrome are particularly susceptible to SARS-CoV-2, a novel coronavirus associated with the severe respiratory disease COVID-19. Despite considerable attention dedicated to COVID-19, the link between metabol...

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901093
Arthritis Research & Therapy; Ferraz-Amaro I, Delgado-Frías E et. al.

Feb 24th, 2021 - It is well established that patients with systemic sclerosis (SSc) have a disrupted lipid profile and an increased cardiovascular risk. Cholesterol efflux capacity (CEC), the ability of high-density lipoprotein (HDL)-cholesterol to accept choleste...

Impact of high visceral adiposity index associated with metabolic syndrome on erectile ...
https://doi.org/10.1111/ijcp.14111
International Journal of Clinical Practice; Bolat MS, Ozbek ML et. al.

Feb 23rd, 2021 - Erectile dysfunction (ED) is a common condition affected by many factors. We aimed to show the impact of the metabolic syndrome (MeTS) on male sexual function based on visceral adiposity index (VAI). Participants who met MeTS criteria (Group 1, n ...

A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897392
Lipids in Health and Disease; Xie B, He J et. al.

Feb 22nd, 2021 - Poor cholesterol efflux capacity (CEC) has been proposed to be an independent risk factor for cardiovascular diseases. However, current evidence is inconsistent, especially in rheumatoid arthritis (RA) patients. This meta-analysis aims to identify...

see more →

News  431 results

Health Coaches at Primary Care Clinics Helped Reduce Heart Risk
https://www.medscape.com/viewarticle/945767

Feb 11th, 2021 - Patients who received intensive lifestyle training by coaches in the primary care setting experienced improvement in several indicators of cardiometabolic health in a 2-year trial. The 803 trial participants comprised a racially diverse, low-incom...

Fast Five Quiz: Lipids Management: High HDL Cholesterol Levels (Hyperalphalipoproteinemia)
https://reference.medscape.com/viewarticle/940625

Dec 2nd, 2020 - Lipoproteins carry insoluble lipids in plasma and transport them to various tissues for deposition, energy production, and steroid hormone or bile acid formation. Lipoproteins are made of esterified and unesterified cholesterol, triglycerides, pho...

Long-Term Cholesterol Risk Points to Need for Earlier Testing
https://www.staging.medscape.com/viewarticle/922136

Dec 3rd, 2019 - New data from almost 400,000 individuals who were followed for up to 43 years have shown that the link between raised non-HDL cholesterol and future risk of cardiovascular disease is strongest in younger people. The researchers also simulated what...

Long-Term Cholesterol Risk Points to Need for Earlier Testing
https://www.medscape.com/viewarticle/922136

Dec 3rd, 2019 - New data from almost 400,000 individuals who were followed for up to 43 years have shown that the link between raised non-HDL cholesterol and future risk of cardiovascular disease is strongest in younger people. The researchers also simulated what...

Bempedoic acid cuts LDL by 15% in patients already on maximal treatment
https://www.mdedge.com/cardiology/article/212279/lipid-disorders/bempedoic-acid-cuts-ldl-15-patients-already-maximal?channel=39313
Michele G. Sullivan

Nov 13th, 2019 - When added to maximally tolerated statin therapy, bempedoic acid reduced LDL cholesterol by more than 15%, compared with placebo, Anne C. Goldberg, MD, and colleagues reported in JAMA.

see more →

Patient Education  9 results see all →